XLON
DUKE
Market cap178mUSD
Jul 09, Last price
26.50GBP
1D
0.95%
1Q
0.95%
Jan 2017
-40.98%
IPO
-97.13%
Name
Duke Royalty Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Duke Capital Limited operates as a private equity firm primarily engaged in Management Buyouts (MBOs), buy-and-build strategies, mid-market investments, minority buyouts, restructuring endeavors, and royalty financing for small to medium-sized enterprises (SMEs). The firm explicitly avoids investing in early-stage ventures, businesses with inherently tight profit margins, and does not provide venture capital funding. While its investment scope spans all sectors, Duke Capital exhibits a distinct preference for companies in manufacturing, services, healthcare, and IT services. Equity investments typically range from £5 million (approximately $6.36 million) to £30 million (around $38.18 million), targeting businesses with an EBITDA between £2 million ($2.54 million) and £10 million ($12.72 million). Additionally, the firm offers debt financing, with loan sizes generally falling between £10 million (approximately $12.72 million) and £30 million (roughly $38.18 million). Key investment criteria include a strong emphasis on intellectual property assets and financially stable, cash-generating businesses. It also favors companies with minimal or no existing debt, and partnerships with owners who wish to retain significant control or with management teams pursuing buyout opportunities. A core strategy involves providing capital in exchange for a modest share of future revenues, via royalty agreements. The firm shows a preference for businesses operating under government or regulatory licenses and generally seeks board representation within its portfolio companies, where it typically acquires minority stakes. Established in 2015, Duke Capital Limited is headquartered in Guernsey, with additional operational bases in both Guernsey and London, United Kingdom.
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||